HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus

Details for Australian Patent Application No. 2004313242 (hide)

Owner Trimeris, Inc.

Inventors Delmedico, Mary K.; Dwyer, John

Agent Watermark

Pub. Number AU-A-2004313242

PCT Pub. Number WO2005/067960

Priority 60/534,810 07.01.04 US

Filing date 21 December 2004

Wipo publication date 28 July 2005

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C07H 19/00 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/067960 Priority application(s): WO2005/067960

16 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004313245-Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH

2004313227-Flexible polymer window